Brief

Addressing the Innovation Divide: Imbalanced innovation

Addressing the Innovation Divide: Imbalanced innovation

Europe is getting a "free ride" on US lab coattails where pharmaceutical research and development is concerned.

  • 읽기 소요시간

Brief

Addressing the Innovation Divide: Imbalanced innovation
en

Europe is getting a "free ride" on US lab coattails where pharmaceutical research and development is concerned. That's the argument being made by US government and business leaders. They complain that pharmaceutical R&D spending has largely shifted to the US, where Americans pay the lion's share of drug development costs. Meanwhile, they argue, consumers in Europe's largest markets enjoy the fruits of that investment-at prices 25-35% lower than those Americans pay. The debate on this issue has grown contentious. Americans charge that Europeans underpay for drugs by imposing onerous regulations on drugmakers that keep prices and utilization artificially low. Europeans retort that Americans overpay for expensive, marginally valuable medicines, thereby funding excessive industry marketing efforts.

태그
태그

베인에 궁금하신 점이 있으신가요?

베인은 글로벌 리더들이 중요한 이슈를 해결하고 기회를 놓치지 않도록 지원합니다. 고객사와 협력하여 지속되는 변화와 성과를 창출합니다.